LipoDual

miRNA Soybean Hydrogel Innovation

LipoDual is a dual-miRNA soybean hydrogel innovation designed to accelerate wound healing through gene-level precision in a sustainable, plant-based system.

Our Story

LipoDual was born from a student-led mission to revolutionize wound care using sustainable biotechnology and cutting-edge gene therapy.

Mission

To accelerate wound healing through innovative miRNA-based therapy delivered via sustainable, plant-derived materials.

Vision

A world where chronic wounds heal faster, reducing patient suffering and healthcare costs through precision biotechnology.

Our Values

Innovation

Pushing boundaries with dual-miRNA gene therapy.

Sustainability

Using eco-friendly soybean-based hydrogels.

Accessibility

Making advanced wound care available globally.

Watch Our Story

The Challenge: Chronic Wounds

Chronic wounds and diabetic ulcers represent a significant global health burden, often leading to severe complications due to ineffective healing processes.

Slow Healing

Standard treatments often fail to address the underlying gene-level dysregulation in chronic wounds.

Infection Risk

Prolonged open wounds increase susceptibility to antibiotic-resistant infections.

High Costs

Long-term care for non-healing wounds places a massive financial strain on healthcare systems.

The LipoDual Solution

An advanced bioactive dressing combining the sustainability of soybean hydrogel with the precision of dual-miRNA therapy.

Dual-miRNA Action

Simultaneously targets key genes to reduce inflammation and promote tissue regeneration.

Soybean Hydrogel

A plant-based, biodegradable scaffold that provides optimal moisture for healing.

Gene-Level Precision

Delivers therapeutic RNA directly to cells to reset the healing cycle.

LipoDual Product

Innovation Model

How LipoDual works: a 4-step mechanism combining soybean hydrogel with dual-miRNA liposomes for accelerated wound healing.

LipoDual Innovation Model Diagram
1

Soybean Hydrogel Scaffold

A biodegradable, plant-based matrix provides structure and moisture retention.

2

Dual Liposome Loading

Two types of liposomes carry miR-21 and miR-29b for dual-action therapy.

3

Protected Delivery

Sustained release protects miRNAs from degradation while ensuring gradual absorption.

4

Gene Modulation & Healing

Target genes are modulated to reduce inflammation and accelerate tissue regeneration.

Unique Value & Sustainability

LipoDual stands out through its innovative use of plant-based materials and genetic precision.

Gene-Level Precision

Unlike conventional dressings, LipoDual targets the root genetic causes of non-healing wounds via dual-miRNA.

Eco-Friendly

Utilizes soybean-derived hydrogel, reducing reliance on synthetic polymers and animal-derived collagen.

Difficult to Replicate

The specific dual-miRNA combination and the novel soybean cross-linking process create a proprietary competitive barrier.

Brand Identity

Dual-Action. Gene-Level. Sustainable.

Our Logo

LipoDual Logo

Brand Name: LipoDual

The name 'LipoDual' combines 'Lipo' (liposome delivery system) with 'Dual' (dual-miRNA action), representing our innovative approach to wound healing through dual-action gene therapy.

Typography

Geist Sans

A modern, professional sans-serif typeface suitable for scientific and medical contexts.

Color Palette

Purple

#7C3AED

Innovation, biotechnology, precision medicine

Green

#10B981

Sustainability, healing, plant-based origins

White/Gray

#FAFAFA

Clinical cleanliness, professionalism

LipoDual Product Mockup 1
LipoDual Product Mockup 2

How It Works

1

Application

The hydrogel is applied directly to the wound site, conforming to the wound bed.

2

Release

miRNAs are sustained-released from the soybean scaffold into the tissue.

3

Regeneration

Target genes are modulated to lower inflammation and accelerate cell migration, closing the wound.

Market & Impact

Driving impact in the global wound care industry.

$25 Billion

Global Wound Care Market

6.5% CAGR

Market Growth Rate

400 Million

Diabetic Patients Globally

Business Model

Cost Structure

R&D & Clinical Trials
40%
Manufacturing (Soybean Processing)
30%
Marketing & Sales
20%
Operations & Admin
10%

Revenue Streams

Direct Sales

Sales to hospitals and wound care clinics.

Licensing

Licensing the hydrogel platform to major pharma companies.

Collaborations

Joint development with biotech firms for new miRNA applications.

Grants

Research grants for sustainable biotech and diabetes care.

Meet the Team

Student Innovation Team

Innovators

A student-led team participating in the Conrad Challenge, developing LipoDual as a sustainable biotechnology innovation for advanced wound healing.

Dr. Reza, MD, SpKK

Clinical & Scientific Advisor

Providing clinical mentorship and scientific guidance.

Innovation Video